NV-VSR-24-001: Supporting Vaccine Confidence
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2024.
Office of the Assistant Secretary for Health offered grants of up to $250,000 (at least $115,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make about 4 awards worth $1.0 million in total. Applications closed on August 21, 2024.
From the official notice on Grants.gov, last changed July 18, 2024. Checked November 7, 2026.
- Award ceiling$250,000
- Award floor$115,000
- Total funding$1.0 million
- Expected awards4
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | July 18, 2024 |
|---|---|
| Deadline | August 21, 2024 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
Is this a realistic fit?
- Past Research, Monitoring and Outcomes Definitions for Vaccine Safety awards averaged $449,286; this notice allows up to $250,000 per award.
- Most of the program's money (60% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The Office of Infectious Disease and HIV/AIDS Policy (OIDP) and the Office of Regional Health Operations (ORHO) are collaborating to implement this initiative. OIDP and ORHO are operational components in the Office of the Assistant Secretary for Health (OASH).This initiative seeks to expand, plan, implement, and evaluate promising practices and develop novel approaches to increase vaccine confidence in local communities, particularly partnerships with organizations that work with populations with low vaccination rates (e.g., African Americans and residents in rural communities). Practical solutions at local levels are needed to help support vaccination efforts in communities by healthcare providers, immunization program managers, immunization advocates, vaccine manufacturers, and other stakeholders. OIDP anticipates the availability of approximately $1,000,000 for this funding opportunity to support four awards ranging from $250,000 to $115,000 per year for up to three years. OIDP and ORHO will support activities by public health departments, community organizations, academic institutions, professional or trade organizations, and immunization coalitions, among others, that work with populations with low vaccination rates. Eligible applicants include any private (either profit or nonprofit) or public entity located in a State. We expect funded projects to involve a local government public health agency or local community-based organization as a partner (if the recipient is neither) in order to meet the goals of this initiative. Successful applicants will have demonstrated a clear understanding of the challenges and needs related to each of the following in the community that is the focus of the project:1. Level of confidence in vaccines.2. Level of confidence in vaccine providers in traditional or non-traditional settings, and 3. Level of confidence in policies including but not limited to the approval process, recommendations for who should and should not receive a vaccine, and when vaccines should be administered.
Who has won Research, Monitoring and Outcomes Definitions for Vaccine Safety grants before
From fiscal 2021 to 2025, Research, Monitoring and Outcomes Definitions for Vaccine Safety (93.344) awarded $3.1 million across 7 grant awards, an average of $449,286 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Cherokee Nation | Oklahoma | 1 | $898,000 |
| Hennepin Healthcare System Inc | Minnesota | 1 | $375,000 |
| Immunize Colorado | Colorado | 1 | $375,000 |
| Chickasaw Nation | Oklahoma | 1 | $375,000 |
| Alliance for a Healthier Generation Inc | Oregon | 1 | $375,000 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is NV-VSR-24-001 still open?
No. It closed on August 21, 2024.
Who can apply for Supporting Vaccine Confidence?
Office of the Assistant Secretary for Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.
What is the deadline for Supporting Vaccine Confidence?
Closed August 21, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $250,000 each. About $1.0 million in total across about 4 awards.
Who has won Research, Monitoring and Outcomes Definitions for Vaccine Safety grants before?
The largest recipients over five fiscal years were Cherokee Nation, Hennepin Healthcare System Inc, Immunize Colorado. The program made 7 awards worth $3.1 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)